GlassScriptPhysician profile
Daniel R Green
NPI 1700288966
$5,625.64
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,926 · 2022: $1,453 · 2023: $1,341 · 2024: $906.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,152 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,152.21 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,208.82 | 2021-2024 | |
| Incyte Corporation | $855.53 | 2021-2024 | Opzelura |
| Genzyme Corporation | $455.72 | 2021-2024 | |
| Sun Pharmaceutical Industries INC. | $404.35 | 2021-2024 | Winlevi, Absorica Ld |
| Lilly USA, LLC | $392.28 | 2021-2024 | Olumiant, Taltz |
| Janssen Biotech, INC. | $391.00 | 2021-2024 | Tremfya |
| Galderma Laboratories, L.P. | $341.03 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $254.89 | 2022-2024 | |
| Ucb, INC. | $207.09 | 2021-2023 | Bimzelx |
| Pfizer INC. | $156.06 | 2022-2023 | |
| Esperion Therapeutics, INC. | $150.00 | 2022 | |
| Vyne Pharmaceuticals INC. | $129.11 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $118.94 | 2022-2024 | Dupixent, Libtayo |
| Leo Pharma INC. | $112.52 | 2021-2024 | Adbry |
| Epi Health, LLC | $100.00 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $90.70 | 2023-2024 | Vtama |
| Amgen INC. | $71.42 | 2021-2024 | Otezla |
| Arcutis Biotherapeutics, INC. | $54.26 | 2023-2024 | Zoryve |
| Abiomed | $44.63 | 2024 | Impella |
| E.R. Squibb & Sons, L.L.C. | $39.80 | 2023-2024 | Sotyktu |
| Almirall LLC | $18.64 | 2021 | |
| Organogenesis INC. | $17.60 | 2022 | |
| Radius Health, INC. | $11.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.